Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism

BACKGROUND & AIMS: Hepatitis C virus (HCV) infection affects 3% of the world population and is the leading cause of chronic liver disease worldwide. Current standard of care is effective in only 50% of the patients, poorly tolerated, and associated with significant side effects and viral resista...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Goldwasser, Jonathan, Cohen, Pazit Y., Lin, Wenyu, Kitsberg, Danny, Balaguer, Patrick, Polyak, Steven J., Chung, Raymond T., Yarmush, Martin L., Nahmias, Yaakov
Formato: Artigo
Idioma:Inglês
Publicado em: 2011
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3197749/
https://ncbi.nlm.nih.gov/pubmed/21354229
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jhep.2011.02.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados